Publication | Open Access

Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer’s disease model

Neurodegenerative DiseasesAlzheimer's DiseaseNeurobiology Of DiseaseDisease ModelMedicineVascular Cognitive DisorderVascular DementiaNeuropharmacologyVascular BiologyPharmacotherapyNeurologyNeuroscienceCognitive DeficitsAlzheimer ’Aging-associated DiseasePharmacologySocial Sciences